Tech Company Financing Transactions

Fate Therapeutics Funding Round

Fate Therapeutics, based in San Diego, received $30 million from OVP Venture Partners, Arch Venture Partners and Polaris Partners.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

3535 General Atomics Ct. 200
San Diego, CA 92121
USA

Phone

(858) 875-1800

Website

www.fatetherapeutics.com

Email Address

[email protected]

Overview

Better Cells for Better Therapies We combine a deep understanding of hematopoietic cell biology with an unmatched expertise in programming cell function and fate. We believe the biological properties of immune cells can be modulated outside the body to impart profound therapeutic effects inside the body upon their administration to a patient.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Scott Wolchko

        

Chief Scientific Officer

Daniel Shoemaker

        

Vice President

Sarah Cooley

        

VP - Bus. Development

James Beitel

        

VP - Bus. Development

Robert Valamehr

        

VP - General Counsel

Cindy Tahl

        

Browse more venture capital transactions:

Prev: 11/16/2009: Swipely venture capital transaction
Next: 11/16/2009: Sezmi venture capital transaction

Share this article

About Database of VC Transactions

Our team works diligently to report on all VC transactions involving tech companies. VC transactions reported here come from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary